Built at the Internet Archive
Subject
Sort By:
Sites for this collection are listed below. Narrow your results at left, or enter a search query below to find a site, specific URL or to search the text of archived webpages.
Page 1 of 1 (3 Total Results)
Sort By:
Description: "The Institute for Precision Medicine at Weill Cornell Medical College and NewYork-Presbyterian Hospital is a translational research hub, which opened under the direction of renowned pathologist and prostate cancer expert Dr. Mark Rubin in 2013. The IPM team includes clinicians, basic scientists, pathologists, molecular biologists, and computational biologists. These physician-scientists are directing their collective expertise and wealth of knowledge to pinpoint the molecular underpinnings of disease and spur the discovery of novel therapies." -- from the website, 6/12/2015
Loading Wayback Capture Info...
Loading video data...
Subject: Cornell University. Joan and Sanford I. Weill Medical College, Institute for Precision Medicine. Weill Cornell Medical College, Biobanks, Computational biology, Research teams, Medical care--Research, Cancer -- Research, Genomics -- Research , Medical care--Research, NewYork-Presbyterian Hospital
Language: English
Identifier: https://hdl.handle.net/1813.001/wa03618
Description: "Founded in 2015, the Englander Institute’s primary mission is to uncover the molecular roots of disease using genomic sequencing, informatics, and other technologies. This information is then used to personalize disease treatment and prevention. To achieve this, computational biologists first analyze tumor sequencing data and summarize the key clinical and genetic findings. Then, a team of interdisciplinary specialists, including pathologists, molecular biologists, oncologists and basic scientists use these findings to determine the best treatment options for each patient. Precision medicine targeted individualized care is tailored to each patient based on his or her specific genetic profile and medical history. Unlike the traditional one-size-fits-all medicine, practitioners of precision medicine use genomic sequencing tools to interrogate a patient’s entire genome to locate the specific genetic alterations that have given rise to and are driving his or her tumor. With this information, they can identify small molecule drugs, monoclonal antibodies, vaccines, and other therapies that are most precisely targeted and are therefore most effective and have the fewest side effects."
Loading Wayback Capture Info...
Loading video data...
Subject: Cornell University. Joan and Sanford I. Weill Medical College, Genomics -- Research , Bioinformatics, Pathology -- Research, Molecular diagnosis
Creator: Weill Cornell Medicine
Language: English
Coverage: Weill Cornell Medicine
Identifier: https://hdl.handle.net/1813.001/wa03607
Description: "As the Sanford I. Weill Chair of the Weill Department of Medicine, I look forward to the extraordinary journey ahead with the utmost enthusiasm. We are indebted to those pioneering physicians and scientists who drove the major discoveries over the past century, but we cannot rest on their laurels. Today's world of translational research offers undiscovered vistas to explore that will open the door to life-saving therapies. An ever-expanding universe of biomedical sciences, genomics, and technological tools will provide the key."
Loading Wayback Capture Info...
Loading video data...
Subject: Cornell University. Joan and Sanford I. Medical College, Medical research, Health care -- Research, Biomedicine, Genomics -- Research , Medical technology
Creator: Weill Cornell Medicine
Language: English
Coverage: Weill Cornell Medicine
Identifier: https://hdl.handle.net/1813.001/wa03529
Page 1 of 1 (3 Total Results)